GILEAD SCIENCES, INC. Short-Term Debt
GILEAD SCIENCES, INC. (GILD) had Short-Term Debt of $2.41 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-08-06
- 2026-06-30: Debt, Current $2.41B.
- 2026-03-31: Debt, Current $1.31B.
- 2025-12-31: Debt, Current $2.81B.
- 2025-09-30: Debt, Current $2.81B.
| Period end | Debt, Current | Debt, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.41B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.31B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.81B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.81B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.81B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.81B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.81B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.81B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.81B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.67B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.80B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.79B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $4.04B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $2.28B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $2.27B 10-K · filed 2024-02-23 | |
| 2022-09-30 | $2.27B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.02B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.02B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.52B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $2.51B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $2.26B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.26B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.76B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $1.50B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $3.00B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.00B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.50B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.50B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.00B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.50B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.75B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.75B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $3.00B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.50B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.75B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $1.75B 10-Q · filed 2017-11-07 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | |
| 2016-09-30 | $700.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $700.00M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.75B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $982.00M 10-K · filed 2017-02-27 | $983.00M 10-K · filed 2016-02-24 |
| 2015-09-30 | $331.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $352.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $442.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $483.00M 10-K · filed 2016-02-24 | |
| 2014-09-30 | $1.48B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $1.57B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $1.87B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $2.70B 10-K · filed 2015-02-25 | $2.70B 10-K · filed 2014-02-25 |
| 2013-09-30 | $1.46B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $1.49B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $942.81M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.17B 10-K · filed 2014-02-25 | |
| 2012-09-30 | $1.73B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.97B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $1.35B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $1.57M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $1.59M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $7.34M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $653.09M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $646.35M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $632.39M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $1.12B 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $7.09M 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $5.59M 10-K · filed 2011-02-28 | |
| 2009-09-30 | $205.61M 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $405.62M 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $5.63M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |